Recent News

• 08.07.2026 - IM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note Financing
• 07.27.2026 - IM Cannabis Provides Corporate Update
• 07.01.2026 - IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
• 06.18.2026 - IM Cannabis Corp. Enters into Letter of Intent to Sell its European Activities, Expects to Significantly Reduce Debt by CAD$10.5 million
• 06.09.2026 - IM Cannabis Announces Form F-3 Resale Registration Statement Filing
• 06.03.2026 - IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
• 05.13.2026 - IM Cannabis Corp. Announces First Quarter 2026 Financial Results
• 05.07.2026 - IM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note Financings
• 04.10.2026 - IMC Announces Receipt of Nasdaq Minimum Bid Price Notification
• 03.31.2026 - IM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134% Growth in Germany and Positive Operating Cash Flow

Recent Filings

• 08.07.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.07.2026 - EX-99.1 EX-99.1
• 07.27.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 07.27.2026 - EX-99.1 EX-99.1
• 07.01.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 07.01.2026 - EX-99.1 EX-99.1
• 06.18.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 06.18.2026 - EX-99.1 EX-99.1
• 06.16.2026 - EFFECT Notice of Effectiveness
• 06.15.2026 - CORRESP Correspondence